Back to results
US 2021/0060145 A1Published application
Dendritic cell vaccination sequential to chemotherapy
AssigneeSOTIO a.s.
InventorsRadek Spisek, Jirina Bartunkova
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a dendritic cell vaccination sequential to chemotherapy, wherein the dendritic cell vaccine is administered to a patient after completion of chemotherapy with at least one chemotherapeutic agent.
Claims17
A method of treatment of cancer comprising administering a dendritic cell vaccine to a patient after completion of chemotherapy with at least one chemotherapeutic agent.
Dependencies are inferred from the claim text.